Losartan and nifedipine therapy in patients with secondary pulmonary hypertension

References (1)

1. Humbert M, Sitbon O, Simonneau G. Treatment of pulmonary arterial hypertension. N Engl J Med 2004; 351: 1425-36. doi:10.1056/NEJMra040291 PMid:15459304 2. Orte C, Polak JM, Haworth SG, Yacoub MH, Morrell NW. Expression of pulmonary vascular angiotensin-converting enzyme in primary and secondary plexiform pulmonary hypertension. J Pathol 2000; 192: 379-84. doi:10.1002/1096-9896(2000)9999:9999_____::AID-PATH715>3.0.CO;2-Q 3. Schuster DP, Crouch EC, Parks WC, Johnson T, Botney MD. Angiotensin converting enzyme expression in primary pulmonary hypertension. Am J Respir Crit Care Med 1996; 154: 1087-91. PMid:8887612 4. Morrell NW, Upton PD, Kotecha S, Huntley A, Yacoub MH, Polak JM, et al. Angiotensin II activates MAPK and stimulates growth of human pulmonary artery smooth muscle via AT1 receptors. Am J Physiol 1999; 277: L440-8. 5. Zielinski J, Hawrylkiewicz I, Gorecka D, Gluskowski J, Koscinska M. Captopril effects on pulmonary and systemic hemodynamics in chronic cor pulmonale. Chest 1986; 90: 562-5. doi:10.1378/chest.90.4.562 PMid:3530649 6. Kiely DG, Cargill RI, Wheeldon NM, Coutie WJ, Lipworth BJ. Haemodynamic and endocrine effects of type 1 angiotensin II receptor blockade in patients with hypoxaemic cor pulmonale. Cardiovasc Res 1997; 33: 201-8. doi:10.1016/S0008-6363(96)00180-0 7. Patakas D, Georgopoulos D, Rodini H, Christaki P. Effects of captopril in patients with chronic obstructive pulmonary disease and secondary pulmonary hypertension. Postgrad Med J 1988; 64: 193-5. doi:10.1136/pgmj.64.749.193 PMid:3050941 PMCid:2428827 8. Kiely DG, Cargill RI, Wheeldon NM, Coutie WJ, Lipworth BJ. Haemodynamic and endocrine effects of type 1 angiotensin II receptor blockade in patients with hypoxaemic cor pulmonale. Cardiovasc Res 1997; 33: 201-8. doi:10.1016/S0008-6363(96)00180-0 9. Morrell NW, Higham MA, Phillips PG, Shakur BH, Robinson PJ, Beddoes RJ. Pilot study of losartan for pulmonary hypertension in chronic obstructive pulmonary disease. Respir Res 2005; 6: 88. doi:10.1186/1465-9921-6-88 PMid:16060962 PMCid:1198258 10. Bozbaş ŞS, Bozbaş H, Atar A, Ulubay G, Eyüboğlu FÖ. Comparative effects of losartan and nifedipine therapy on exercise capacity, Doppler echocardiographic parameters and endothelin levels in patients with secondary pulmonary hypertension. Anadolu Kardiyol Derg 2010; 10: 43-9. DOI: 10.5152/akd.2010.010 PMID: 20150004 11. Siva A, Shah AM. Moderate mitral stenosis in pregnancy: the haemodynamic impact of diuresis. Heart 2005; 9: e3. doi:10.